Does STERIS' (STE) 21-Year Dividend Streak Reveal Its True Capital Allocation Priorities?

STERIS plc has increased its quarterly interim dividend for the 21st consecutive year, raising it to US$0.69 per share. This consistent dividend growth, alongside a new US$1,000 million share repurchase program, highlights STERIS's commitment to shareholder returns. The article discusses how these capital allocation decisions fit into STERIS's overall investment narrative, which projects significant revenue and earnings growth by 2029, even as it faces potential risks from healthcare reimbursement pressures.